FNY Investment Advisers’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

FNY Investment Advisers’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,000	Closed	-$92K	–	815
2023 Q2	$92K	Buy	+2,000	New	+$69.1K	0.12%	119

FNY Investment Advisers's DICE Position: Q3 2023 in Review

FNY Investment Advisers sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 2,000 shares — an estimated $92K sold.

FNY Investment Advisers first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $92K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

FNY Investment Advisers reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
FNY Investment Advisers sold 2,000 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $92K.
FNY Investment Advisers first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
FNY Investment Advisers's DICE Therapeutics, Inc. Common Stock position peaked at $92K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on FNY Investment Advisers's 13F filing for Q3 2023, filed 10 Oct 2023.